Macrogenics reported $-22111000 in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Amgen AMGN:US USD 3.5B 62M
AstraZeneca AZN:LN USD 3.6B 404M
Biogen BIIB:US USD 992.8M 82.9M
Bristol Myers Squibb BMY:US USD 5.32B 456M
Daiichi Sankyo 4568:JP JPY 76.31B 27.06B
Eli Lilly And LLY:US USD 2.31B 308.9M
Gilead Sciences GILD:US USD 3.28B 731M
Immunogen IMGN:US USD -77005000 16.41M
Johnson & Johnson JNJ:US USD 7.81B 876M
Karyopharm Therapeutics KPTI:US USD -30657000 12.1M
Macrogenics MGNX:US USD -22111000 16.82M
Mirati Therapeutics MRTX:US USD -185727000 9.22M
Pfizer PFE:US USD 10.52B 2.78B
Regeneron Pharmaceuticals REGN:US USD 1.33B 49.4M
Seattle Genetics SGEN:US USD -175213000 59.32M
Xencor XNCR:US USD -36110000 10.33M